The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions

Journal of Cutaneous Pathology

Volumn 37, Issue SUPPL. 1, 2010, Pages 54-59

  Cochran, Alistair J ^a,b   Binder, Scott ^a   Morton, Donald L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLUE NEVUS; DIFFERENTIAL DIAGNOSIS; HUMAN; LYMPH NODE METASTASIS; LYMPHOCYTE; MELANOCYTE; MELANOMA; METASTASIS; PATHOLOGY; PIGMENTED NEVUS; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHATIC METASTASIS; LYMPHOCYTES; MELANOCYTES; MELANOMA; NEVUS, BLUE; NEVUS, PIGMENTED; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 77949855801     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2010.01509.x     Document Type: Article

References (26)

1. Edwards SL, Blessing K. Problematic pigmented lesions: approach to diagnosis. J Clin Pathol 2000 53 : 409.
2. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992 127 : 392.
3. Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ. Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 2002 26 : 47.
4. Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer 2003 97 : 499.
5. Gamblin TC, Edington H, Kirkwood JM, Rao UN. Sentinel lymph node biopsy for atypical melanocytic lesions with spitzoid features. Ann Surg Oncol 2006 37 : 816.
6. Urso C, Borgognoni L, Saieva C, et al. Sentinel lymph node biopsy in patients with "atypical Spitz tumors." A report on 12 cases. Hum Pathol 2006 37 : 816.
7. Murali R, Sharma RN, Thompson JF, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol 2008 15 : 302.
8. Busam KJ, Pulitzer M. Sentinel lymph node biopsy for patients with diagnostically controversial spitzoid melanocytic tumors. Adv Anat Pathol 2008 15 : 253.
9. Andreola S, Clemente C. Nevus cells in axillary lymph nodes from radical mastectomy specimens. Pathol Res Pract 1985 179 : 616.
10. Bautista NC, Cohen S, Anders KH. Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review. Am J Clin Pathol 1994 102 : 102.
11. Carson KF, Wen D-R, Li PX, Lana AM, Bailly C, Morton DL. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996 20 : 834.
12. Fontaine D, Parkhill W, Greer W, Walsh N. Nevus cells in lymph nodes: an association with congenital cutaneous nevi. Am J Dermatolopathol 2002 24 : 1.
13. Holt JB, Sangueza OP, Levine EA, et al. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi. Am J Clin Pathol 2004 121 : 58.
14. Zaharopaulos P, Hudnall SD. Nevus-cell aggregates in lymph nodes: fine-needle aspiration cytologic findings and resulting diagnostic difficulties. Diagn Cytopathol 2004 31 : 180.
15. Biddle DA, Evans HL, Kemp BL, et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol 2003 27 : 673.
16. Ohsie S, Binder SW, Cochran AJ, Sarantopoulos GP. Immunohistochemical characteristics of melanoma. J Cutan Pathol 2008 35 : 433.
17. Gerami P, Jewell SS, Morrison LE, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 2009 33 : 1146.
18. Van't Veer LJ, Burgering BM, Versteeg R, et al. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol 1989 9 : 3114.
19. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 1998 111 : 757.
20. Bastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 1999 113 : 1065.
21. Mihic-Probst D, Zhao J, Saremaslani P, Baer A, Komminoth P, Heitz PU. Spitzoid malignant melanoma with lymph-node metastasis: is a copy-number loss on chromosome 6q a marker of malignancy? Virchows Arch 2001 439 : 823.
22. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003 163 : 1765.
23. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM. High frequency of BRAF mutations in nevi. Nat Genet 2003 33 : 19.
24. Gill M, Renwick N, Silvers DN, Celebi JT. Lack of BRAF mutations in Spitz nevi. J Invest Dermatol 2004 122 : 1325.
25. Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Therapy 2006 19 : 40.
26. DaForno PD, Fletcher A, Pringle JH, Saldanha GS. Understanding spitzoid tumours: new insights from molecular pathology. Br J Dermatol 2008 158 : 4.